Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Illustration of the progression of COVID-19 over a 100 day time period. by Mackenzie Dalton (14093874)

Analysis of the ¹H–¹⁵N HSQC spectrum of the labeled RAGE V domain with unlabeled S100A12. by Jian Wei Chiou (3106578)

“…<p>(a) Overlay of the ¹H–¹⁵N HSQC spectra of 0.5 mM ¹⁵N-labeled RAGE V domain (red) and the spectra of the complex with 0.5 mM unlabeled S100A12 (blue). …”

Analysis of the ¹H–¹⁵N HSQC spectra of S100A12 in complex with the unlabeled RAGE V domain. by Jian Wei Chiou (3106578)

“…<p>(a) Overlay of the ¹H–¹⁵N HSQC spectra of 0.76 mM ¹⁵N-labeled S100A12 (red) and S100A12 in complex with 0.76 mM unlabeled RAGE V domain (green). …”

Aβ and 22C11 agonist decreased cholesterol uptake whereas the sAPP-derived peptide and SM-ϕ stimulated increased cholesterol uptake by Caco-2 cells. by Kendra L. Puig (334788)

Anti-TNF Thioester Glucocorticoid Antibody–Drug Conjugate Fully Inhibits Inflammation with Minimal Effect on Systemic Corticosterone Levels in a Mouse Arthritis Model by Christopher C. Marvin (1338228)

“…We describe the discovery of a thioester-containing glucocorticoid receptor modulator (GRM) payload and the corresponding antibody–drug conjugate (ADC). …”

Anti-TNF Thioester Glucocorticoid Antibody–Drug Conjugate Fully Inhibits Inflammation with Minimal Effect on Systemic Corticosterone Levels in a Mouse Arthritis Model by Christopher C. Marvin (1338228)

“…We describe the discovery of a thioester-containing glucocorticoid receptor modulator (GRM) payload and the corresponding antibody–drug conjugate (ADC). …”

Feasibility diagram of design points. by Xueyong Pan (20390363)

The importance of entry criteria from the point of view of the SD method ‐ combination A. by Roman Vavrek (13200141)

All data points from Fig 2. by Sara Hijazi (21656615)

All data points from Fig 5. by Sara Hijazi (21656615)

All data points from Fig 8. by Sara Hijazi (21656615)

All data points from Fig 3. by Sara Hijazi (21656615)

All data points from Fig 1. by Sara Hijazi (21656615)

All data points from Fig 4. by Sara Hijazi (21656615)

All data points from Fig 9. by Sara Hijazi (21656615)

All data points from Fig 7. by Sara Hijazi (21656615)

All data points from Fig 6. by Sara Hijazi (21656615)

Pitfalls of merging only considering end-points. by Almiqdad Elzein (13141038)

Decreased proteasome activities of the 26S proteasome in A549 and H1299 tumor spheres. by Jing Pan (95938)